How does arginine effect on the course of tuberculosis? Experimental trial

I. Diachkov (Yekaterinburg, Russian Federation), I. Medvinskiy (Yekaterinburg, Russian Federation), E. Sabadash (Yekaterinburg, Russian Federation), S. Skornyakov (Yekaterinburg, Russian Federation), V. Kotomtsev (Yekaterinburg, Russian Federation), V. Pavlov (Yekaterinburg, Russian Federation), E. Ivanchikova (Yekaterinburg, Russian Federation)

Source: International Congress 2018 – Challenges in tuberculosis care
Session: Challenges in tuberculosis care
Session type: Thematic Poster
Number: 2685
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
I. Diachkov (Yekaterinburg, Russian Federation), I. Medvinskiy (Yekaterinburg, Russian Federation), E. Sabadash (Yekaterinburg, Russian Federation), S. Skornyakov (Yekaterinburg, Russian Federation), V. Kotomtsev (Yekaterinburg, Russian Federation), V. Pavlov (Yekaterinburg, Russian Federation), E. Ivanchikova (Yekaterinburg, Russian Federation). How does arginine effect on the course of tuberculosis? Experimental trial. 2685

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The effect of text messaging on latent tuberculosis treatment adherence: a randomised controlled trial
Source: Eur Respir J, 51 (2) 1701488; 10.1183/13993003.01488-2017
Year: 2018



Paradoxical reactions during treatment of tuberculosis: A prospective study
Source: Annual Congress 2010 - Adverse events of antituberculosis treatment and comorbidities
Year: 2010

Effect of exacerbation history on response to treatment in the TORCH trial
Source: Eur Respir J 2007; 30: Suppl. 51, 356s
Year: 2007

Supplementation of N-acetylcysteine as an adjuvant in treatment of newly diagnosed pulmonary tuberculosis patients: A prospective, randomized double blind, placebo controlled study
Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection: diagnosis and treatment
Year: 2013

Late Breaking Abstract: High-dose vitamin D3 during intensive phase treatment of pulmonary tuberculosis: A double-blind randomised controlled trial
Source: Annual Congress 2010 - Clinical tuberculosis
Year: 2010

Routine liver function test monitoring of patients treated for active M.TB infection does not influence management: A real-world retrospective study
Source: International Congress 2018 – Challenges in tuberculosis care
Year: 2018

Maintenance after pulmonary rehabilitation in COPD: a randomised trial. Preliminary results
Source: Eur Respir J 2004; 24: Suppl. 48, 245s
Year: 2004

The clinical effect of combined therapy according to guidelines on the treatment of pulmonary Mycobacterium avium complex disease - including a long-term follow-up study
Source: Eur Respir J 2004; 24: Suppl. 48, 721s
Year: 2004

Feasibility of shortening intravenous antibiotic therapy for bronchiectasis based on bacterial load: a proof-of-concept randomised controlled trial
Source: Eur Respir J, 58 (6) 2004388; 10.1183/13993003.04388-2020
Year: 2021



The effect of smoking on the treatment outcome in patients with pulmonary tuberculosis: A prospective cohort study
Source: Annual Congress 2011 - Clinical tuberculosis
Year: 2011


Experimental hookworm infection as potential therapy for asthma: a randomised placebo controlled trial
Source: Annual Congress 2009 - Epidemiology of atopy and asthma
Year: 2009

Pulmonary tuberculosis control: does COVID-19 have any effect?
Source: Virtual Congress 2021 – Tuberculosis, COVID-19 and other comorbidities
Year: 2021


Does hospitalization influence tuberculosis’ treatment outcome? – A Portuguese nationwide study
Source: International Congress 2018 – Challenges in treating tuberculosis and nontuberculous mycobacteria
Year: 2018



Effects of distance to treatment centre and case load upon tuberculosis treatment completion
Source: Eur Respir J 2011; 38: 1223-1225
Year: 2011


Safety and benefit of adjunctive systemic corticosteroid therapy in the management of severe, smear positive pulmonary tuberculosis (SSP-PTB); an interim analysis of a randomized controlled trial
Source: Annual Congress 2012 - Tuberculosis: clinical findings II
Year: 2012


Granulamatous mastitis treated as tuberculosis: Preliminary results of surveillance programme
Source: Annual Congress 2012 - Tuberculosis: clinical findings III
Year: 2012

A cross-over study to compare the Lung Flute™ to hypertonic saline inhalation about the performance of inducing sputum for the diagnosis of pulmonary tuberculosis
Source: International Congress 2015 – Management of TB: a patient focus
Year: 2015


Effect of vitamin A & zinc supplementation on clinical response &nutritional status in patients with tuberculosis getting standard chemotherapy: a double blind, placebo control study in Bangladesh
Source: Eur Respir J 2004; 24: Suppl. 48, 722s
Year: 2004

Treatment of latent tuberculosis infection: completion rates and adverse effects
Source: Eur Respir J 2003; 22: Suppl. 45, 526s
Year: 2003

New short regimens for latent tuberculosis treatment: safety first!
Source: Eur Respir J, 52 (6) 1802180; 10.1183/13993003.02180-2018
Year: 2018